|This Slide: #76 of 83|
Slide #76. PerkinElmer — Shanghai Haoyuan Biotech Co., Ltd.,
Shanghai Haoyuan Biotech Co., Ltd.,
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, announced today that it has completed the acquisition of Shanghai Haoyuan Biotech Co., Ltd., a China-based infectious disease diagnostics company. The acquisition extends PerkinElmer's capabilities into nucleic acid blood screening and in the growing molecular clinical diagnostics market in China, further strengthening the Company's position as a diagnostics leader in China as well as across the globe.
PerkinElmer provides products, services and solutions for the diagnostics, life sciences and applied markets. Co.'s segments are: Discovery and Analytical Solutions, which provides solutions such as reagents, informatics, and detection and imaging technologies in the life sciences research market, and develops and provides analytical technologies, solutions and services in the applied markets; and Diagnostics, which provides instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research personnel, and provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market.
PerkinElmer SEC Filing Email Alerts Service
Open the PKI Page at The Online Investor »
Buy (3.00 out of 4)